Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2020-06-25 , DOI: 10.1056/nejmoa1916624
Alessandro Doria ₁ , Andrzej T Galecki ₁ , Cathie Spino ₁ , Rodica Pop-Busui ₁ , David Z Cherney ₁ , Ildiko Lingvay ₁ , Afshin Parsa ₁ , Peter Rossing ₁ , Ronald J Sigal ₁ , Maryam Afkarian ₁ , Ronnie Aronson ₁ , M Luiza Caramori ₁ , Jill P Crandall ₁ , Ian H de Boer ₁ , Thomas G Elliott ₁ , Allison B Goldfine ₁ , J Sonya Haw ₁ , Irl B Hirsch ₁ , Amy B Karger ₁ , David M Maahs ₁ , Janet B McGill ₁ , Mark E Molitch ₁ , Bruce A Perkins ₁ , Sarit Polsky ₁ , Marlon Pragnell ₁ , William N Robiner ₁ , Sylvia E Rosas ₁ , Peter Senior ₁ , Katherine R Tuttle ₁ , Guillermo E Umpierrez ₁ , Amisha Wallia ₁ , Ruth S Weinstock ₁ , Chunyi Wu ₁ , Michael Mauer ₁ ,

Affiliation

From the Research Division, Joslin Diabetes Center, and the Department of Medicine, Harvard Medical School, Boston (A.D., A.B.G., S.E.R.); the Division of Geriatrics, Institute of Gerontology (A.T.G., C.W.), the Department of Biostatistics, School of Public Health (A.T.G., C.S.), Statistical Analysis of Biomedical and Educational Research (SABER) (C.S.), and the Department of Internal Medicine, Metabolism, Endocrinology, and Diabetes (R.P.-B.), University of Michigan, Ann Arbor; the Departments of Medicine, Physiology, and Pharmacology and Toxicology (D.Z.C.) and the Division of Endocrinology and Metabolism (B.A.P.), University of Toronto, the Division of Nephrology, University Health Network (D.Z.C.), LMC Diabetes and Endocrinology (R.A.), and Lunenfeld-Tanenbaum Research Institute, Sinai Health System (B.A.P.), Toronto, the Departments of Medicine, Cardiac Sciences, and Community Health Sciences, Faculties of Medicine and Kinesiology, University of Calgary, Calgary, AB (R.J.S.), BCDiabetes, Vancouver (T.G.E.), and the Division of Endocrinology, University of Alberta, Edmonton (P.S.) - all in Canada; the Departments of Medicine and Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas (I.L.); the Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (A.P.); Steno Diabetes Center, and the Department of Clinical Medicine, University Copenhagen, Copenhagen (P.R.); the Division of Nephrology, Department of Medicine, University of California, Davis (M.A.), and the Department of Pediatrics and Stanford Diabetes Research Center, Stanford University, Palo Alto (D.M.M.) - both in California; the Departments of Medicine and Pediatrics (M.L.C., W.N.R.. M.M.) and Laboratory Medicine and Pathology (A.B.K.), University of Minnesota, Minneapolis; the Division of Endocrinology and Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine (J.P.C.), and JDRF (Juvenile Diabetes Research Foundation) (M.P.), New York; the Department of Medicine (I.H.B., I.B.H.) and the Nephrology Division (K.R.T.), University of Washington, and the Institute of Translational Health Sciences, Kidney Research Institute (K.R.T.), Seattle, and Providence Health Care, Spokane (K.R.T.) - both in Washington; the Department of Medicine, Emory University, Atlanta (J.S.H., G.E.U.); the Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis (J.B.M.); the Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago (M.E.M., A.W.); the Barbara Davis Center for Diabetes, University of Colorado, Aurora (S.P.); and the Department of Medicine, State University of New York Upstate Medical University, Syracuse (R.S.W.).

New England Journal of Medicine, Volume 382, Issue 26, Page 2493-2503, June 2020.

中文翻译：